Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 8.34
-0.24 (-2.80%)
At close: Jan 23, 2026
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 1.09 billion as of January 23, 2026. Its market cap has decreased by -47.94% in one year.
Market Cap
1.09B
Enterprise Value
1.23B
Revenue
1.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
8.34
Market Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 1.09B, an increase of 279.62%. That is a compound annual growth rate of 17.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 1.09B | -3.25% |
| Dec 31, 2025 | 1.12B | -46.84% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 9.36B |
| Sigachi Industries | 9.06B |
| Ind-Swift Laboratories | 8.67B |
| Valiant Laboratories | 3.13B |
| Nectar Lifesciences | 3.11B |
| Bafna Pharmaceuticals | 2.65B |
| Brooks Laboratories | 1.92B |
| Alpa Laboratories | 1.32B |